PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29088827-5	2017	Knocking down c-Myc sensitized ovarian cancer cells to 7-difluoromethoxyl-5,4"-di-n-octylgenistein (DFOG), a novel synthetic genistein analogue that suppressed PI3K/AKT signaling in vitro and in vivo.	7-difluoromethoxyl-5,4'-di-n-octylgenistein	55-98	AKT serine/threonine kinase 1	Homo sapiens	165-168	
29088827-5	2017	Knocking down c-Myc sensitized ovarian cancer cells to 7-difluoromethoxyl-5,4"-di-n-octylgenistein (DFOG), a novel synthetic genistein analogue that suppressed PI3K/AKT signaling in vitro and in vivo.	7-difluoromethoxyl-5,4'-di-n-octylgenistein	100-104	AKT serine/threonine kinase 1	Homo sapiens	165-168	
29088827-7	2017	These results indicate that nuclear c-Myc expression is an unfavorable factor in early ovarian cancer, and that let-7d increases ovarian cancer cell sensitivity to DFOG by suppressing c-Myc and PI3K/AKT signaling.	7-difluoromethoxyl-5,4'-di-n-octylgenistein	164-168	AKT serine/threonine kinase 1	Homo sapiens	199-202